--2025/Q1-- / 12.500M--
--2024/Q4-- / 0.000--
Nov 13, 20242024/Q30.000 / 25.833M--
Aug 13, 20242024/Q20.000 / 0.000--
May 8, 20242024/Q10.000 / 250.000K--
US Stock MarketDetailed Quotes
MCRB Seres Therapeutics
- 0.756
- -0.058-7.14%
Trading Nov 21 11:18 ET
129.04MMarket Cap-3599P/E (TTM)
0.880High0.750Low2.53MVolume0.822Open0.814Pre Close2.07MTurnover2.03%Turnover RatioLossP/E (Static)170.74MShares2.05052wk High5.40P/B94.37MFloat Cap0.54052wk Low--Dividend TTM124.86MShs Float52.000Historical High--Div YieldTTM15.87%Amplitude0.540Historical Low0.816Avg Price1Lot Size
Seres Therapeutics Key Stats
Seres Therapeutics Q3 2024 Earnings Date
Currency：USDNov 13, 2024
| Estimate (YoY) | Actual (YoY) | Vs Estimate (% Chg) | |
| Revenue | 25.83M | 0 | -25.83M |
| Miss Est. | +8233.33% | -- | -100.00% |
| EPS | -0.08 | 0.58 | +0.66 |
| Beat Est. | +78.94% | +256.76% | +844.54% |
Analyst Rating
Nov 14, 2024
Seres Therapeutics Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Seres Therapeutics Earnings Reports
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
